A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes

Clinical trial NCT01408888 · COMPLETED

Trial details

NCT number: NCT01408888
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2011-08-01
Primary completion: 2012-04-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.